The symposium was a two-day hybrid event that featured seminars and panel discussions from expert researchers and clinicians in five focus areas: precision medicine, innovative technology, mitochondrial system dysfunctions, immune system dysfunction, and systems biology.

Invited speakers, from regional to international, focused on the current and desired future state of rare disease research and advocated for greater understanding and therapeutic interventions for rare diseases and rare cancers.

Through this symposium we were able to meet our goals to 1) share and promote novel strategies for genomic analyses and precision medicine, 2) foster cross-disciplinary collaborations, and 3) initiate an annual gathering for rare disease and rare cancer researchers.

We eagerly anticipate the opportunity to welcome all participants at the symposium next year, where we hope to engage in new insightful discussions and collaborations.